A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma.

Pratt, Guy, Yap, Christina, Oldreive, Ceri, Slade, Daniel, Bishop, Rebecca, Griffiths, Mike, Dyer, Martin J S, Fegan, Chris, Oscier, David, Pettitt, Andrew, Matutes, Estella, Devereux, Stephen, Allsup, David, Bloor, Adrian, Hillmen, Peter, Follows, George, Rule, Simon, Moss, Paul and Stankovic, Tatjana (2018) A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma. British journal of haematology, 182 (3). pp. 429-433. ISSN 1365-2141. This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs

Full text not available from this repository.
Official URL: https://onlinelibrary.wiley.com/doi/full/10.1111/b...
Item Type: Article
Additional Information: This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs
Subjects: QZ Pathology. Oncology
WH Haemic and lymphatic systems. Haematology
Divisions: Planned IP Care > Oncology and Clinical Haematology
Related URLs:
Depositing User: Beth Connors
Date Deposited: 21 Jun 2019 11:23
Last Modified: 21 Jun 2019 11:23
URI: http://www.repository.uhblibrary.co.uk/id/eprint/2164

Actions (login required)

View Item View Item